Contact Group Leader

 

Prof.Dr.med.Dr.phil. Eva Winkler

E-mail: eva.winkler@med.uni-heidelberg.de

Significant Accomplishments

Practical Acchievements

  • EURAT Position Paper (Cornerstones for an ethically and legally informed practice of Whole Genome Sequencing: Code of Conduct and patient consent models)
  • Ethical framework for evaluating a patient's request for life-prolonging treatment
  • Guideline on changing and communicating the goal of care (curative to palliative)
  • Ongoing Interdisciplinary seminar series about ethical conflicts in decision- making (in Collaboration with the Department of Hematology/Oncology, Radiation Therapy, Theology, Psychology)
  • Establishment of a working group “Medicine and Ethics” at the German Society for Hematology and Oncology

Publications

  • Mehlis K, Winkler EC. „Ethische Analyse lebensverlängernder Behandlungen. Zum Schutz der Selbstbestimmung und zum Schutz vor Übertherapie“ Der Onkologe 2016; Online First, DOI 10.1007/s00761-016-0109-2

  • Winkler EC, Heussner P. „Vorausschauende Behandlungsplanung und Therapiebegrenzung. Überlegungen aus medizinethischer und psychoonkologischer Sicht“ Dtsch Med Wochenschr 2016; 141: 394-398

  • Winkler EC, Ose D, Glimm H, Tanner K, von Kalle C.” Personalized Medicine and Informed Consent: Clinical and ethical considerations fora best practice guideline for biobank based Whole Genome Research in Oncology. Ethik in der Medizin 2013, Vol 25, 169-172

  • Krause SW, Schildmann J; Lotze Ch; Winkler EC, "Rationing Cancer Care: A Survey Among the Members of the German Society of Hematology and Oncology" J NatlComprCancNetw 2013;11:658-665

  • Winkler EC, Hiddmann W, Marckmann G „ Evaluating a patient’s request for life-prolonging treatment: An ethical decision aid“ Lancet Oncology August 2011, Vol 11, 720-22.

  • Hauke D, Reiter-Theil S, Hoster E., Hiddemann W., Winkler, EC  “The role of relatives in decisions concerning life-prolonging treatment in patients with endstage malignant disorders: Informants, advocates or surrogate decision-makers. Ann Oncol. 2011 Dec;22(12):2667-74

  • Winkler EC, Reiter-Theil S, Lange-Rieß D, Schmal-Menges N, Hiddemann W; Patient involvement in decisions to limit treatment: the crucial role of agreement between physician and patient. J ClinOncol 2009 (27) :2225-2230

Funding

  • German CancerAid - Deutsche Krebshilfe e.V.
  • German Ministryfor Education and Research (Bundesministerium für Bildung und Forschung
  • Early Clinical development Research (DKFZ)
  • Marsilius-Kolleg (Initiative of Excellence)

Honors and Awards

  • Lohfert Prize 2016 (20.000 €) for the EPAL-project: Heußner P, Winkler EC. “Treatment limitation: improvement of shared decision-making with cancer patients“


  • Best Poster Award: Laryionava K, Sklenarova H, Heußner P, Hartmann M, Winkler EC. “Decision Making in Oncology at the End of Life: Patient’s Preferences for Quality or Length of Life.” Ethics and Evidence in end-of-life decision making - Interdisciplinary Perspectives. 3. -4. April 2014, Bochum, Deutschland

  • Roche Faculty Award (10.000 SFR) for the best dissertation 2010, University of Basel, Switzerland: Winkler EC. “Challenges at the End of Life: Involving Patients and Family Members in Decisions Concerning the Determination of Medical Care”